Literature DB >> 9379431

Parotid gland metastases of two uncommon neoplasms with low metastatic potential.

H K Williams1, A M Brown, P C Barber.   

Abstract

Oligodendrogliomas are uncommon intracranial glial tumours in which extracranial spread is only rarely reported. Similarly, both intracranial and ocular medulloepitheliomas are also rare, with metastatic spread from the ocular neoplasm being less common than its intracranial counterpart. We report cases of an intracranial oligodendroglioma and an ocular medulloepithelioma both of which metastasised to the parotid gland. To our knowledge these are only the second oligodendroglioma and the third ocular medulloepithelioma to be reported as metastasising to this site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379431     DOI: 10.1111/j.1600-0714.1997.tb00237.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  4 in total

1.  Oligodendroglioma metastatic to bone marrow.

Authors:  Firas Al-Ali; Aaron J Hendon; Marcia K Liepman; Jennifer L Wisniewski; Mark J Krinock; Kevin Beckman
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 2.  A survey of metastatic central nervous system tumors to cervical lymph nodes.

Authors:  Vanni Mondin; Alfio Ferlito; Kenneth O Devaney; Julia A Woolgar; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-08       Impact factor: 2.503

3.  Molecular diagnosis of metastasizing oligodendroglioma: a case report.

Authors:  Min Wang; Kathleen M Murphy; Piotr Kulesza; Kimmo J Hatanpaa; Alessandro Olivi; Anthony Tufaro; Yener Erozan; William H Westra; Peter C Burger; Karin D Berg
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

Review 4.  Cervical Lymph Node Metastases from Central Nervous System Tumors: A Systematic Review.

Authors:  Andrés Coca-Pelaz; Justin A Bishop; Nina Zidar; Abbas Agaimy; Eloisa Maria Mello Santiago Gebrim; Vanni Mondin; Oded Cohen; Primož Strojan; Alessandra Rinaldo; Ashok R Shaha; Remco de Bree; Marc Hamoir; Antti A Mäkitie; Luiz P Kowalski; Nabil F Saba; Alfio Ferlito
Journal:  Cancer Manag Res       Date:  2022-03-09       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.